| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MAHON PAUL A | EVP & GENERAL COUNSEL | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 2025-05-02 | 0001231589 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $1.3M | +11K | +29.91% | $117.76 | 47.8K | May 1, 2025 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | -$257K | -870 | -1.82% | $295.12 | 46.9K | May 1, 2025 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | -$118K | -400 | -0.85% | $296.00 | 46.5K | May 1, 2025 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | -$71K | -239 | -0.51% | $297.00 | 46.3K | May 1, 2025 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | -$89.4K | -300 | -0.65% | $298.05 | 46K | May 1, 2025 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | -$150K | -500 | -1.09% | $299.05 | 45.5K | May 1, 2025 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | -$397K | -1.32K | -2.9% | $300.63 | 44.2K | May 1, 2025 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | -$1.02M | -3.39K | -7.68% | $301.81 | 40.8K | May 1, 2025 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | -$1.17M | -3.86K | -9.47% | $302.71 | 36.9K | May 1, 2025 | Direct | F1, F9 |
| transaction | UTHR | Common Stock | Sale | -$36.4K | -120 | -0.33% | $303.38 | 36.8K | May 1, 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | $0 | -11K | -42.31% | $0.00 | 15K | May 1, 2025 | Common Stock | 11K | $117.76 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. |
| F2 | This transaction was executed in multiple trades at prices ranging from $294.71 to $295.6225. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $295.76 to $296.715. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $296.855 to $297.105. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $297.915 to $298.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $298.975 to $299.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $300.23 to $301.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $301.335 to $302.315. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $302.34 to $303.215. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |